Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR3 | P29371 | 12/20 | 0.58 |
| ▸ | TACR2 | P21452 | 8/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.49 |
| ▸ | KCNK3 | O14649 | 6/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | TACR1 | P25103 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1717050 | 1.00 | TACR3 (0.58) | TACR3TACR2OPRM1KCNK3CYP1A2 | |
| SCHEMBL1718057 | 0.99 | TACR3 (0.56) | TACR3TACR2OPRM1KCNK3CYP1A2 | |
| SCHEMBL1717937 | 0.97 | TACR3 (0.54) | TACR3TACR2OPRM1KCNK3CYP1A2 | |
| SCHEMBL1717394 | 0.96 | TACR3 (0.54) | TACR3TACR2OPRM1KCNK3CYP1A2 | |
| SCHEMBL1718258 | 0.95 | TACR3 (0.53) | TACR3TACR2OPRM1KCNK3CYP1A2 | |
| SCHEMBL1725621 | 0.95 | TACR3 (0.53) | TACR3TACR2OPRM1KCNK3CYP1A2 | |
| SCHEMBL1717583 | 0.94 | TACR3 (0.51) | TACR3TACR2OPRM1KCNK3CYP1A2 | |
| SCHEMBL1718974 | 0.94 | TACR3 (0.51) | TACR3TACR2OPRM1KCNK3CYP1A2 | |
| SCHEMBL1718231 | 0.92 | TACR3 (0.49) | TACR3TACR2OPRM1CYP1A2CYP3A4 | |
| SCHEMBL1716918 | 0.92 | TACR3 (0.49) | TACR3TACR2OPRM1KCNK3CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2150534-B1 | ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS | LUNDBECK & CO AS H (DK) | 2012-01-11 | — | — | EP | claimed |
| EP-2150534-B1 | ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS | LUNDBECK & CO AS H (DK) | 2012-01-11 | — | — | EP | disclosed |